Prognostic utility of BRAF mutation in papillary thyroid cancer
- 28 May 2010
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 321 (1) , 86-93
- https://doi.org/10.1016/j.mce.2009.10.012
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid CancerJournal of Clinical Oncology, 2009
- Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less Than 2 cm: Implications for Radioiodine TreatmentJournal of Clinical Endocrinology & Metabolism, 2009
- Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependencyClinical Endocrinology, 2009
- BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk ManagementAnnals of Surgical Oncology, 2009
- High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid CarcinomaClinical Cancer Research, 2009
- The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative StudyPLOS ONE, 2009
- The Prevalence and Prognostic Value of BRAF Mutation in Thyroid CancerAnnals of Surgery, 2007
- Extent of Surgery Affects Survival for Papillary Thyroid CancerAnnals of Surgery, 2007
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Mutations of the BRAF gene in human cancerNature, 2002